Shilan Ding

机构：Ministry of Education of the People's Republic of China, Chinese Academy of Medical Sciences & Peking Union Medical College, State Administration of Traditional Chinese Medicine of the People's Republic of China

发表论文 17 篇 · 总被引 364 次 · h-index 9

代表论文

Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells (2020 · Frontiers in Pharmacology · 被引 79)
Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation (2018 · Oncotarget · 被引 78)
Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa (2024 · International Journal of Nanomedicine · 被引 37)
Inhibition of Shear-Induced Platelet Aggregation by Xueshuantong via Targeting Piezo1 Channel-Mediated Ca2+ Signaling Pathway (2021 · Frontiers in Pharmacology · 被引 37)
Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice (2013 · Journal of Ethnopharmacology · 被引 34)
D-dencichine Regulates Thrombopoiesis by Promoting Megakaryocyte Adhesion, Migration and Proplatelet Formation (2018 · Frontiers in Pharmacology · 被引 33)